Abstract
The effect of the novel antianginal agent molsidomine on the incidence of spontaneous ventricular fibrillation during myocardial ischemia and reperfusion was investigated in the anesthetized dog. Molsidomine was administered as an intravenous bolus at the dose of 0.05 mg/kg. Twenty minutes later, the left anterior descending coronary artery was occluded for 90 min. During the occlusion period, molsidomine was given as a continuous intravenous infusion at the dose of 0.5 μg/kg per ml per min. After release of the occlusion, the animals that survived were monitored for another 30 min. Control animals received saline. In the control animals, coronary occlusion was accompanied by an increase in heart rate, heart contractility, left ventricular end-diastolic pressure, and blood pressure as well as by ventricular arrhythmias. Molsidomine either abolished or reduced both hemodynamic and electrical changes. During the reperfusion period, 10 out of 12 control animals died, and the deaths were from ventricular fibrillation; one out of eight molsidomine-treated animals also died of ventricular fibrillation. It is postulated that the protective effect of molsidomine rests on its hemodynamic effects resulting in a shift in blood flow toward the ischemic zones and, consequently, in an increase in ventricular electrical stability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berdeaux, A., Tato, F., Ho, S., Boissier, J. R., and Giudicelli, J. F. 1978. Molsidomine, debits coronaires regionaux et segment ST au niveau du myocarde sain et/ou ischemique chez le chien. J. Pharmacol. (Paris) 9:219–234.
Brooks, W. W., Verrier, R. L., and Lown, B. 1980. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Car-diovasc. Res. 14:295–302.
Brown, A. M. 1967. Excitation of cardiac afferent sympathetic nerve fibres during myocardial ischemia. J. Physiol. (Lond.) 190:35–53.
Bussmann, W. D., Neidel, K., and Kaltenbach, M. 1979. Wirkung von Molsidomin auf Hämodynamik und Ischämie bei Patienten mit frischem Herzinfarkt. In: W. Lochner and F. Bender (eds.), Molsidomin, Neue Aspekte in der Therapie der ischämischen Herzerkrankung, pp. 100–104. Urban & Schwarzenberg, Munich.
Corbalan, R., Verrier, R. L., and Lown, B. 1976. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am. Heart J. 92:223–230.
Fiedler, V. B., and Scholtholt, J. 1978. Hemodynamic effects of molsidomine. Arzneim. Forsch. 9:1605–1612.
Fleck, E., Dirschinger, J., and Rudolph, W. 1979. Hämodynamische Wirkungen von Molsidomin bei koronarer Herzerkrankung. Herz 4:285–292.
Grund, E., Müller-Rucholtz, E. R., and Lapp, E. R., Lösch, H. M., and Lochner, W. 1978. Comparative study of nitroglycerin and molsidomine. Effects of the integrated systemic venous bed and the arterial pressure in dogs. Arzneim. Forsch. 9:1624–1628.
Hashimoto, K., Taira, N., Hirata, M., and Kokubun, M. 1971. The mode of hypotensive action of newly synthesized sydnonimine derivatives. Arzneim. Forsch. 21:1329–1332.
Hearse, D. J. 1977. Reperfusion of ischemic myocardium. J. Mol. Cell. Cardiol. 9:607–616.
Holtz, J., Bassenge, E., and Kolin, A. 1978. Hemodynamic and myocardial effects of long lasting venodilatation in the conscious dog: Analysis of molsidomine in comparison with nitrates. Basic Res. Cardiol. 73:469–481.
Karsch, K. R., Rentrop, K. P., Blanke, H., and Kreuzer, H. 1978. Hemodynamic effects of molsidomine. Eur. J. Clin. Pharmacol. 13:241–245.
Kikuchi, K., Hirata, M., and Nagaoka, A. 1970. Hypotensive action of N-ethoxycarbonyl-3-morpholinosydnonimine, SIN-10. Jpn. J. Pharmacol. 20:102–115.
Majid, P. A., DeFeyter, P. J. F., van der Wall, E. E., Warden, R., and Roos, J. P. 1980. Molsidomine in the treatment of patients with angina pectoris. Acute hemodynamic effects and clinical efficacy. N. Engl. J. Med. 302:1–6.
Malliani, A., Schwartz, P. J., and Zanchetti, A. 1969. A sympathetic reflex elicited by experimental coronary occlusion. Am. J. Physiol. 217:703–709.
Nayler, W. G. 1980. The pharmacological protection of the ischemic heart. The use of calcium and beta-adrenoceptor antagonists. In: Abstracts, VII European Congress of Cardiology, Paris, p. 242.
Ribeiro, L. G. T., DeBauche, T. L., Brandon, T. A., Reduto, L. A., Maroko, P. R., and Miller, R. R. 1980. Comparative effects of calcium antagonists on reactive hyperemia and ventricular arrhythmias during coronary artery reperfusion. In: Abstracts, VII European Congress of Cardiology, Paris, p. 242.
Scholtholt, J., Fiedler, V. B., and Keil, M. 1978. Die Wirkung von Molsidomin und Nitroglycerin auf die regionale Durchblutung des normalen und akutischämischen Myokards. Arzneim. Forsch. 28:1619–1624.
Scholtholt, J., Fiedler, V. B., and Keil, M. 1978. Die Wirkung von Molsidomin auf die regionale Verteilung des Herzminutenvolumens des narkotisierten Hundes. Arzneim. Forsch. 28:1612–1619.
Stockman, M. B., Verrier, R. L., and Lown, B. 1979. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am. J. Cardiol. 43:233–238.
Surawicz, B. 1971. Ventricular fibrillation. Am. J. Cardiol. 28:268–287.
Takenaka, F., Takeya, N., Ishihara, T., Inoue, S., Tsutsumi, E., Nakamura, R., Mitsufuji, Y., and Sumie, M. 1970. Effects of N-ethoxycarbonyl-3-morpholinosydnonimine (SIN-10) on cardiovascular system. Jpn. J. Pharmacol. 20:253–263.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Martorana, P.A., Mogilev, A.M., Kettenbach, B., Nitz, RE. (1983). Effect of Molsidomine on Spontaneous Ventricular Fibrillation following Myocardial Ischemia and Reperfusion in the Dog. In: Chazov, E., Saks, V., Rona, G. (eds) Advances in Myocardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4441-5_59
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4441-5_59
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-4443-9
Online ISBN: 978-1-4757-4441-5
eBook Packages: Springer Book Archive